Back
Corporate News
Aurobindo Pharma reported dematerialization details to Indian exchanges, per regulatory requirements
05-Oct-2026, 02:17
Aurobindo Pharma Limited, in a filing on October 5, 2026, certified that details of dematerialized and rematerialized securities for the quarter ended September 30, 2026, have been furnished to the National Stock Exchange of India Limited and BSE Limited, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, with confirming letters from KFin Technologies Limited dated October 1, 2026, enclosed for reference.